Population-based screening strategies for biliary atresia in the newborn: A systematic review and meta-analysis
PLOS ONE · 28.08.2024 · 19 (8) · e0307837
DOI: 10.1371/journal.pone.0307837 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 28.08.2024. Verfasst von Srirupa Hari Gopal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatal-Perinatal Medicine, Baylor College of Medicine & Texas Children's Hospital, Houston, Texas, United States of America. Hauptthemen laut MEDLINE: Biliary Atresia, Neonatal Screening. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Background
Newborn screening for biliary atresia (BA) may facilitate earlier diagnosis and intervention for improved clinical outcomes.
Methods
We systematically reviewed the accuracy of population-based screening strategies for BA in the newborn using PRISMA-DTA guidelines. We included cohort or cross-sectional studies. The screening (index) tests included stool color card (SCC) and direct/conjugated bilirubin (DB/CB) and the reference standard was intraoperative cholangiogram. Meta-analysis was performed using random-effects logistic regression models.
Results
We included 15 studies (1,816,722 participants) that assessed 5 different population-based screening strategies. QUADAS-2 assessment revealed high risk of bias for patient selection in one study and uncertain risks for reference standard in multiple studies. High certainty evidence suggests that DB/CB assessed after birth had a summary sensitivity of 100% (95% CI 100,100) and specificity of 98.8% (98.8,98.9) (5 studies, 662141 participants). Moderate certainty evidence suggests that SCC screening at a month of age had summary sensitivity of 79.6% (95% CI 70.6, 86.4) and specificity of 99.9% (95% CI 99.9, 99.9) (7 studies, 996262 participants).
Conclusions
DB/CB in the first few days of life has the best diagnostic accuracy for population screening for biliary atresia in the newborn. Future research should focus on cost-effectiveness and combinations of screening strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neonatal-Perinatal Medicine, Baylor College of Medicine & Texas Children's Hospital, Houston, Texas, United States of America.
- University of Pennsylvania, Philadelphia, PA, United States of America.
- Division of Pediatric Gastroenterology, Baylor College of Medicine & Texas Children's Hospital, Houston, Texas, United States of America.
- Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
ORCID-Profile: Srirupa Hari Gopal, Yemisi Takwoingi, Mohan Pammi
Förderung
- NICHD NIH HHS
- National Institute of Child Health and Human Development
Zitieren
APA
Gopal, S. H., Zebda, R., Mohan, A., Borovsky, K., Takwoingi, Y., Scandrett, K., & Pammi, M. (2024). Population-based screening strategies for biliary atresia in the newborn: A systematic review and meta-analysis. PLOS ONE, 19(8), e0307837. https://doi.org/10.1371/journal.pone.0307837
Vancouver
Gopal SH, Zebda R, Mohan A, Borovsky K, Takwoingi Y, Scandrett K, et al. Population-based screening strategies for biliary atresia in the newborn: A systematic review and meta-analysis. PLOS ONE. 2024;19(8):e0307837. doi:10.1371/journal.pone.0307837
BibTeX
@article{Gopal2024,
author = {Gopal, Srirupa Hari and Zebda, Rema and Mohan, Arvind and Borovsky, Kristin and Takwoingi, Yemisi and Scandrett, Katie and Pammi, Mohan},
title = {Population-based screening strategies for biliary atresia in the newborn: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {8},
pages = {e0307837},
doi = {10.1371/journal.pone.0307837}
}
EUVIMED